Anne Samuel
Stock Analyst at JP Morgan
(2.95)
# 1,562
Out of 4,670 analysts
54
Total ratings
45%
Success rate
0.55%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $45 → $15 | $11.25 | +33.33% | 10 | Nov 22, 2024 | |
| IQV IQVIA Holdings | Maintains: Overweight | $279 → $240 | $201.82 | +18.92% | 5 | Nov 5, 2024 | |
| PGNY Progyny | Maintains: Overweight | $31 → $22 | $15.44 | +42.49% | 5 | Sep 19, 2024 | |
| VEEV Veeva Systems | Maintains: Neutral | $203 → $208 | $216.58 | -3.96% | 4 | Sep 9, 2024 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $19.87 | +40.92% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $22.84 | -16.81% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $24.49 | -14.25% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $8.13 | +59.90% | 3 | Sep 4, 2024 | |
| OMCL Omnicell | Maintains: Neutral | $26 → $37 | $45.69 | -19.02% | 3 | Aug 23, 2024 | |
| DOCS Doximity | Maintains: Neutral | $27 → $30 | $48.20 | -37.76% | 4 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $31.25 | -13.60% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $4.37 | +14.42% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $104.25 | +3.60% | 8 | Apr 2, 2024 |
Evolent Health
Nov 22, 2024
Maintains: Overweight
Price Target: $45 → $15
Current: $11.25
Upside: +33.33%
IQVIA Holdings
Nov 5, 2024
Maintains: Overweight
Price Target: $279 → $240
Current: $201.82
Upside: +18.92%
Progyny
Sep 19, 2024
Maintains: Overweight
Price Target: $31 → $22
Current: $15.44
Upside: +42.49%
Veeva Systems
Sep 9, 2024
Maintains: Neutral
Price Target: $203 → $208
Current: $216.58
Upside: -3.96%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $19.87
Upside: +40.92%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $22.84
Upside: -16.81%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $24.49
Upside: -14.25%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $8.13
Upside: +59.90%
Omnicell
Aug 23, 2024
Maintains: Neutral
Price Target: $26 → $37
Current: $45.69
Upside: -19.02%
Doximity
Aug 19, 2024
Maintains: Neutral
Price Target: $27 → $30
Current: $48.20
Upside: -37.76%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $31.25
Upside: -13.60%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $4.37
Upside: +14.42%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $104.25
Upside: +3.60%